Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Integrating Eastern and Western Medicine for Treatment of Granulomatous Mastitis
Published on: May 3, 2024
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells
Bose S Kochupurakkal1, J Dirk Iglehart2
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Abstract:
The molecular mechanisms responsible for opposing oncogenic and tumor-suppressor activities of NF-kB are obscure. Semi-quantitative immunohistochemistry of primary breast tumors using antibodies to RelA, the pleiotropic NF-kB factor, and Ki67 revealed a negative correlation between RelA levels and Ki67-index among ER +/HER2 - tumors [1]. Similarly, expression of AURKA, a marker for proliferation, negatively correlates with expression of NFKBIA, a surrogate for RelA expression and activity, in ER +/HER2 - tumors analyzed by The Cancer Genome Atlas [2], [3], [4]. Furthermore, conditional expression of RelA using a Tetracycline-inducible system in Human Mammary Epithelial Cells (HRA cells) caused proliferation arrest while withdrawal of Doxycycline (Dox) and suppression of RelA expression in arrested cells restored cell cycle progression [1]. To identify genes responsible for the negative relationship between RelA levels and proliferation, we performed genome-wide gene expression analysis of HRA cells under the following conditions: RelA un-induced, No Dox (ND); Dox induced for 24 h; Dox induced for 72 h; Dox induced for 24 h then Dox withdrawn for 48 h. The expression data was submitted to Gene Expression Ominibus (GEO) and the accession number is GSE65040. Analysis of the data identified cross-talk between basal RelA activity and the Interferon pathway mediated by IRF1, a target of RelA [5]. Activation of the Interferon pathway lead to down-regulation of CDK4 expression resulting in RB1 hypo-phosphorylation and suppression of cell cycle progression. The tumor-suppressor activity of NF-kB, specifically RelA, may stem from cross-talk with the Interferon pathway.
Insights
Nuclear factor-kappa B (NF-kB) factor RelA suppresses tumor growth by activating the Interferon pathway, downregulating CDK4, and halting cell cycle progression. This uncovers a novel tumor-suppressor role for NF-kB.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- The dual role of Nuclear Factor-kappa B (NF-kB) as both an oncogene and tumor suppressor is not fully understood.
- Previous studies indicated a negative correlation between RelA (a key NF-kB factor) levels and proliferation markers (Ki67, AURKA) in estrogen receptor-positive/HER2-negative (ER+/HER2-) breast tumors.
- Conditional expression of RelA in Human Mammary Epithelial Cells (HRA cells) induced proliferation arrest, which was reversible upon RelA suppression.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the tumor-suppressive function of NF-kB, specifically RelA.
- To identify genes mediating the negative correlation between RelA levels and cell proliferation.
Main Methods:
- Semi-quantitative immunohistochemistry of primary breast tumors.
- Analysis of The Cancer Genome Atlas (TCGA) data for ER+/HER2- tumors.
- Genome-wide gene expression analysis using a Tetracycline-inducible RelA system in HRA cells under various induction and withdrawal conditions.
- Data submission to Gene Expression Omnibus (GEO) under accession number GSE65040.
Main Results:
- A negative correlation was observed between RelA levels and Ki67-index in ER+/HER2- breast tumors.
- Gene expression analysis revealed cross-talk between RelA activity and the Interferon pathway, mediated by IRF1.
- Activation of the Interferon pathway led to decreased CDK4 expression, resulting in RB1 hypo-phosphorylation and cell cycle arrest.
Conclusions:
- NF-kB, particularly RelA, exhibits tumor-suppressor activity through its interaction with the Interferon pathway.
- The identified pathway (RelA -> IRF1 -> Interferon pathway -> CDK4 downregulation -> RB1 hypo-phosphorylation) explains the antiproliferative effect of RelA.
- This finding provides novel insights into the complex role of NF-kB in cancer and suggests potential therapeutic targets.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Replicative Cell Senescence

